Clinical Trial Update: An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia [Phase 2]

View source ↗

Summary

An extension Phase 2 trial is evaluating the safety and efficacy of BMN 111 (vosoritide) in children with Achondroplasia; the study is currently ACTIVE_NOT_RECR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• BMN-111 (vosoritide)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Achondroplasia | Phase 2 | Status: ACTIVE_NOT_RECRUITING